AgNOR analysis of ER-positive and ER-negative cells in breast cancer.

被引:0
|
作者
Guski, H [1 ]
Winzer, KJ [1 ]
Hufnagl, P [1 ]
Gunther, L [1 ]
机构
[1] HUMBOLDT UNIV BERLIN,CHIRURG KLIN,KLINIKUM CHARITE,BERLIN,GERMANY
来源
EUROPEAN JOURNAL OF HISTOCHEMISTRY | 1996年 / 40卷 / 04期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:341 / 341
页数:1
相关论文
共 50 条
  • [31] Comprehensive gene expression analysis predicts postoperative prognosis of ER-negative breast cancer.
    Nagahata, T
    Onda, M
    Fujimoto, T
    Tsumagari, K
    Nagai, H
    Kasumi, F
    Emi, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S81 - S81
  • [32] Induction of Redox-Mediated Cell Death in ER-Positive and ER-Negative Breast Cancer Cells by a Copper(II)-Phenolate Complex: An In Vitro and In Silico Study
    Periasamy, Vaiyapuri Subbarayan
    Riyasdeen, Anvarbatcha
    Rajendiran, Venugopal
    Palaniandavar, Mallayan
    Krishnamurthy, Hanumanthappa
    Alshatwi, Ali Abdullah
    Akbarsha, Mohammad Abdulkader
    [J]. MOLECULES, 2020, 25 (19):
  • [33] Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis
    Gan, Siyuan
    Dai, Haixia
    Li, Rujia
    Liu, Wang
    Ye, Ruifang
    Ha, Yanping
    Di, Xiaoqing
    Hu, Wenhua
    Zhang, Zhi
    Sun, Yanqin
    [J]. GLAND SURGERY, 2020, 9 (03) : 661 - 675
  • [34] A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells
    Zhang, X. T.
    Kang, L. G.
    Ding, L.
    Vranic, S.
    Gatalica, Z.
    Wang, Z-Y
    [J]. ONCOGENE, 2011, 30 (07) : 770 - 780
  • [35] A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells
    X T Zhang
    L G Kang
    L Ding
    S Vranic
    Z Gatalica
    Z-Y Wang
    [J]. Oncogene, 2011, 30 : 770 - 780
  • [36] Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
    Floris H. Groenendijk
    Tina Treece
    Erin Yoder
    Paul Baron
    Peter Beitsch
    William Audeh
    Winand N. M. Dinjens
    Rene Bernards
    Pat Whitworth
    [J]. npj Breast Cancer, 5
  • [37] Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
    Groenendijk, Floris H.
    Treece, Tina
    Yoder, Erin
    Baron, Paul
    Beitsch, Peter
    Audeh, William
    Dinjens, Winand N. M.
    Bernards, Rene
    Whitworth, Pat
    [J]. NPJ BREAST CANCER, 2019, 5 (1)
  • [38] Mechanisms of primary AI resistance in ER-positive HER2-negative breast cancer.
    Miura, Daishu
    Iwatani, Tsuguo
    Kawabata, Hidetaka
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] CD133 expression is associated with less DNA repair, better response to chemotherapy, and survival in ER-positive/ER-negative breast cancer
    Sato, Takumi
    Oshi, Masanori
    Lee, Jing
    Roy, Arya M.
    Chida, Kohei
    Endo, Itaru
    Obayashi, Masato
    Takabe, Kazuaki
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [40] Restoration of ER expression and antiestrogen response in ER-negative breast cancer
    Bayliss, Jill
    Hilger, Amy
    El-Ashry, Dorraya
    [J]. CANCER RESEARCH, 2006, 66 (08)